Search Results 141-150 of 16695 for alopecia

1. Head and neck cancers - Doctors and departments - Mayo Clinic

   ... Alopecia areata, Melasma. Show more areas of focus for Ashley B. Wentworth, M.D.. Josh P. Wiedermann, M.D.. Otolaryngologist. Rochester ...

2. Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer - Mayo Clinic

   Patients with well-controlled hyper/hypothyroidism, celiac controlled by diet alone, diverticulosis, diabetes mellitus type I, vitiligo, alopecia, psoriasis ...

3. Mayo Clinic Q and A: Cold cap therapy can reduce hair loss caused by chemotherapy

   DEAR MAYO CLINIC: How effective is cold cap therapy in preventing hair loss in people undergoing chemotherapy treatments? Are there any risks?

4. Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia - Mayo Clinic

   ... alopecia. Known bleeding disorders (e.g., von Willebrand's disease) or hemophilia. Unwilling or unable to participate in all required study evaluations and ...

5. Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma - Mayo Clinic

   ... alopecia and/or endocrinopathies related to prior immunotherapy which are controlled with hormone replacement - ELIGIBILITY CRITERIA (STEP 1): Patients must ...

6. Study of Iopofosine I 131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) and Pivotal Expansion in Waldenstrom Macroglobulinemia (CLOVER-WaM) - Mayo Clinic

   - Ongoing Grade 2 or greater toxicities due to previous therapies, excluding alopecia. - Prior external-beam RT resulting in greater than 20% of total bone ...

7. A Study to Evaluate IMGN632 with Venetoclax and/or Azacitidine to Treat Patients with CD123-Positive Acute Myeloid Leukemia - Mayo Clinic

   Previous treatment-related toxicities must have resolved to Grade 1 or baseline (excluding alopecia). Total white blood cell count must be less than 25 × 10 ...

8. Age spots (liver spots) - Doctors and departments - Mayo Clinic

   Lichen sclerosus, Lichen planus, Skin wrinkles, Vulvar disorder, Acne, Alopecia areata, Melasma, Age spots, UV skin damage, Rosacea, Canker sores, Actinic ...

9. Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors, The PNeoVCA Study - Mayo Clinic

   ... alopecia or vitiligo). * PRE-REGISTRATION: Hemoglobin \>= 9.0 g/dL (obtained =\< 28 days prior to pre-registration) (Must be \>= 7 days after most recent ...

10. A Study to Assess the Safety and Dose Escalation of Pegtomarginase (PT01) for Subjects with Advanced Malignancies - Mayo Clinic

    03) except for subjects with alopecia; subjects receiving luteinizing hormone-releasing hormone agonists may be considered for enrollment after discussion with ...